What changed in this filing

/stocks — the workspaceLOADING

Item 2. Unregistered Sales of Equity Securities

2025-11-05 compared with 2025-08-14 · 28 added, 30 removed, 5 unchanged (92% of the section changed)

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following information relates to the registration

statement on Form S-1 (File Number 333-280026), as amended (the “Registration Statement”) for our initial public offering

(the “IPO”), which was declared effective by the SEC on October 10, 2024.

On October 15, 2024, we consummated our IPO of 5,000,000

Each Unit consists of one Ordinary Share, and one Right to receive one-tenth (1/10) of one Ordinary Share upon the consummation

of an initial business combination.

The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $50,000,000.

Pursuant to that certain underwriting agreement, dated October 10, 2024, we granted Lucid Capital Markets, LLC, the representative of

the underwriters, a 45-day option to purchase up to an additional 750,000 Units solely to cover over-allotments, if any, or the Over-Allotment

Simultaneously with the consummation of the IPO, the underwriters exercised the Over-Allotment Option in full, generating total

proceeds of $7,500,000.

Simultaneously with the closing of the IPO on

October 15, 2024, we consummated the Private Placement with Aurora Beacon LLC, or the Sponsor, of 254,375 Private Units, generating total

proceeds of $2,543,750.

following information relates to the registration statement on Form S-1 (File Number 333-280026), as amended (the “Registration

Statement”) for our initial public offering (the “IPO”), which was declared effective by the SEC on October 10, 2024.

On October 15, 2024, we consummated our IPO of 5,000,000 Units.

Each Unit consists of one Ordinary Share, and one Right to receive one-tenth

(1/10) of one Ordinary Share upon the consummation of an initial business combination.

The Units were sold at an offering price of $10.00

per Unit, generating gross proceeds of $50,000,000.

Pursuant to that certain underwriting agreement, dated October 10, 2024, we granted

Lucid Capital Markets, LLC, the representative of the underwriters, a 45-day option to purchase up to an additional 750,000 Units solely

to cover over-allotments, if any, or the Over-Allotment Option.

Simultaneously with the consummation of the IPO, the underwriters exercised

the Over-Allotment Option in full, generating total proceeds of $7,500,000.

Simultaneously

with the closing of the IPO on October 15, 2024, we consummated the Private Placement with Aurora Beacon LLC, or the Sponsor, of 254,375

Private Units, generating total proceeds of $2,543,750.

The Private Units are identical to the Units sold in the IPO.

Additionally, the Sponsor agreed not to transfer,

assign, or sell any of the Private Units or underlying securities (except in limited circumstances, as described in the Registration Statement)

until 30 days after the completion of our initial business combination or earlier if, subsequent to our initial business combination,

we consummate a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of our shareholders having

the right to exchange their ordinary shares for cash, securities or other property.

The Sponsor was granted certain demand and piggyback

registration rights in connection with the purchase of the Private Units.

On October 15, 2024, a total of $57,787,500 of

the net proceeds from the sale of the Units in the IPO and the Private Placement were deposited in a trust account established for the

benefit of the Company’s public shareholders at JPMorgan Chase Bank, N.A.

maintained by Continental Stock Transfer & Trust Company,

acting as trustee.

We paid a total of $1,006,250 in underwriting

discounts (excluding deferred underwriting discount of $1,868,750) and $556,288 for other costs and expenses related to the IPO.

For a description of the use of the proceeds generated

in our IPO, see Part I, Item 2 of this Quarterly Report.

Additionally, the

Sponsor agreed not to transfer, assign, or sell any of the Private Units or underlying securities (except in limited circumstances, as

described in the Registration Statement) until 30 days after the completion of our initial business combination or earlier if, subsequent

to our initial business combination, we consummate a subsequent liquidation, merger, stock exchange or other similar transaction which

results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property.

was granted certain demand and piggyback registration rights in connection with the purchase of the Private Units.

October 15, 2024, a total of $57,787,500 of the net proceeds from the sale of the Units in the IPO and the Private Placement were deposited

in a trust account established for the benefit of the Company’s public shareholders at JPMorgan Chase Bank, N.A.

maintained by

Continental Stock Transfer & Trust Company, acting as trustee.

paid a total of $1,006,250 in underwriting discounts (excluding deferred underwriting discount of $1,868,750) and $556,288 for other

costs and expenses related to the IPO.

a description of the use of the proceeds generated in our IPO, see Part I, Item 2 of this Quarterly Report.

DEFAULTS UPON SENIOR SECURITIES

2 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 2. Unregistered Sales of Equity Securities